‘Fitness, fresh air and forward thinking’: Cape to Cape for Cannabis delivers a new kind of …
#55 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
# Cannabis Clinical Summary Medical Cannabis Research Australia (MCRA) organized the Cape to Cape for Cannabis event, which included continuing professional development education aimed at advancing clinician knowledge in cannabis medicine. The initiative reflects growing professional recognition that structured education and networking opportunities are essential for practitioners in an emerging field with evolving evidence and clinical applications. By integrating educational programming with community engagement, the event supports the development of evidence-based cannabis prescribing practices and helps clinicians stay current with research developments and regulatory changes. Such professional development activities are particularly important given the heterogeneous quality of cannabis information available and the need for standardized clinical guidance in this rapidly evolving area. For clinicians, participation in organized educational forums like this helps establish best practices for patient assessment, dosing, and monitoring while contributing to the professionalization of cannabis medicine in Australia. Clinicians seeking to prescribe cannabis responsibly should engage with accredited professional development opportunities and evidence-based educational resources from recognized medical organizations.
“What we’re seeing with events like Cape to Cape is the medical community finally catching up to where patients already are, and that matters because clinicians who understand cannabis pharmacology and drug interactions can actually help people use it safely rather than pretend it doesn’t exist in their practice.”
🏥 While educational initiatives like Cape to Cape for Cannabis can help increase healthcare provider familiarity with cannabis pharmacology and clinical applications, clinicians should approach such industry-affiliated continuing education with careful consideration of potential sponsorship bias and commercial interests. The quality and rigor of cannabis-focused professional development varies widely, and providers need to critically evaluate whether content is grounded in robust clinical evidence or reflects promotional messaging, particularly given the still-emerging evidence base for most therapeutic cannabis indications. That said, structured education for healthcare providers remains important, since evidence suggests many clinicians feel inadequately trained to counsel patients about cannabis use or to recognize cannabis use disorder and cannabis hyperemesis syndrome. Practitioners should seek out balanced, evidence-based educational resources that present both efficacy data and harms, drug interaction risks, and patient screening considerations, so they can provide informed guidance regardless of whether cannabis may be therapeutically relevant for their patient population.
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
